Periodic Reporting for period 2 - MEDLEM (Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments)

Worldwide, more than a quarter of a million people are diagnosed with leukaemia each year – including around 75 000 in Europe – accounting for 2.5 % of all cancers. Significantly, the disease accounts for 35 % of all cancers in children up to the age of 14.Though leukaemia...